Artificial Intelligence (AI) is being incorporated into various medical devices, including imaging machines for faster scans and lesion detection, wearables for heart arrhythmia detection, and software systems for predicting sepsis risk in hospitals. This trend has prompted regulators to clarify their positions on AI in medical devices. As this happens,...
AdvaMed Code of Ethics to Guide India’s MedTech Sector
Washington D.C.-headquartered Advanced Medical Technology Association (AdvaMed) launched a Code of Ethics on interactions with health care professionals in India. It provides medical technology and diagnostics makers with compliance principles and guidance that address key legal risk areas governing business relationships and activities. This Code is intended to help companies...
India's Med Tech Industry Partners with Ayushman Bharat
Representatives of the Medical Technology Association of India, Advance Medical Technology Association, AmCham Medical Devices Committee, AmCham Medical Devices Committee, Healthcare Federation of India, and Federation of Indian Chambers of Commerce and Industries, discussed ways to strengthen healthcare delivery under Ayushman Bharat a government program to enable the bottom 40...
India Regulator to Review Stent Price Controls
In July 2016, the Government of India decided to cap the prices of drug-eluting and bare-metal stents, and in February 2017, the ceiling price of bare metal stents was set at $108, while the price of drug-eluting stents was set at $442 before taxes, which for some products was a...
AdvaMed Promotes Medical Device Regulation in India
The medical devices sector in India needs to be regulated in harmonization with international practices and should to be treated as separate from 'drugs', trade association AdvaMed declared. Washington DC-based AdvaMed represents 80 percent of medical technology firms in the US and its member companies produce more than 40 percent...